Chemoinformaics analysis of Methyl-Ent-8beta-Hydroxy-Labd-E-13-En-15-Oate
Molecular Weight | 366.542 | nRot | 6 |
Heavy Atom Molecular Weight | 328.238 | nRig | 13 |
Exact Molecular Weight | 366.277 | nRing | 2 |
Solubility: LogS | -4.334 | nHRing | 0 |
Solubility: LogP | 4.254 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 22 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 65.2861 |
nHD | 1 | BPOL | 42.4619 |
QED | 0.546 |
Synth | 4.54 |
Natural Product Likeliness | 2.052 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.989 |
Pgp-sub | 0.004 |
HIA | 0.005 |
CACO-2 | -4.702 |
MDCK | 0.0000244 |
BBB | 0.696 |
PPB | 0.633371 |
VDSS | 0.657 |
FU | 0.415756 |
CYP1A2-inh | 0.058 |
CYP1A2-sub | 0.464 |
CYP2c19-inh | 0.347 |
CYP2c19-sub | 0.903 |
CYP2c9-inh | 0.49 |
CYP2c9-sub | 0.244 |
CYP2d6-inh | 0.016 |
CYP2d6-sub | 0.225 |
CYP3a4-inh | 0.838 |
CYP3a4-sub | 0.576 |
CL | 6.702 |
T12 | 0.643 |
hERG | 0.03 |
Ames | 0.014 |
ROA | 0.069 |
SkinSen | 0.912 |
Carcinogencity | 0.108 |
EI | 0.51 |
Respiratory | 0.972 |
NR-Aromatase | 0.011 |
Antiviral | Yes |
Prediction | 0.749715 |